ask="N/A"
ask_size="N/A"
average_daily_volume="20800"
bid="N/A"
bid_size="N/A"
book_value="0.45"
change="+0.00"
change_from_200_day_moving_average="0.16"
change_from_50_day_moving_average="0.12"
change_from_52_week_high="-1.29"
change_From_52_week_low="2.14"
change_in_percent="+0.00%"
close="4.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.44"
ebitda="-14.69M"
eps_estimate_current_year="-1.69"
eps_estimate_next_quarter="-0.02"
eps_estimate_next_year="-0.25"
ex_dividend_date="N/A"
float_shares="4889000"
high="4.09"
high_52_weeks="5.29"
last_trade_date="3/3/2017"
last_trade_price="4.00"
last_trade_size="100"
last_trade_time="4:02pm"
low="3.80"
low_52_weeks="1.86"
market_capitalization="60.54M"
moving_average_200_day="3.84"
moving_average_50_day="3.88"
name="NovaBay Pharmaceuticals
Inc. C"
notes="N/A"
one_year_target_price="6.75"
open="4.09"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+4.19%"
percent_change_from_50_day_moving_average="+3.16%"
percent_change_from_52_week_high="-24.39%"
percent_change_from_52_week_low="+115.07%"
previous_close="4.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.85"
price_per_sales="6.40"
revenue="9.45M"
shares_outstanding="15134000"
short_ratio="6.33"
stock_exchange="ASE"
symbol="NBY"
volume="14480"
weeks_range_52="1.86 - 5.29"
